Irradiation technology

  • Hepatitis C and HIV prophylaxis: microwave reduces viral transmission in the drugs scene

    PD Dr. Eike Steinmann und Anindya Siddharta. TWINCORE/Romy Weller

    Infections with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) among people who inject drugs (PWID) are a global health problem. For example, sharing of drug preparation equipment within this population contributes to more than 80% of newly acquired HCV infections. As a response to these circumstances, scientists at TWINCORE validated a simple and safe method to reduce the risk of viral transmission, namely by microwave irradiation. This method has been published recently in Scientific Reports.

  • New procedure for producing safe and more effective vaccines

    Foto Fraunhofer FEP

    A consortium of four Fraunhofer Institutes (the Fraunhofer Institute for Cell Therapy and Immunology IZI, Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, Fraunhofer Institute for Manufacturing Engineering and Automation IPA, and the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB) is developing a way of inactivating viruses and other pathogens based on low energy electron irradiation. This may aid the manufacture of more effective, safe and also more cost-effective vaccines.